Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Feasibility Study of Oral Etoposide Given Concurrently With Radiotherapy Followed With Dose Intensive Adjuvant Chemotherapy for Children With Newly Diagnosed High Stage Medulloblastoma

NCT00003573 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Feasibility Study of Oral Etoposide Given Concurrently With Radiotherapy Followed With Dose Intensive Adjuvant Chemotherapy for Children With Newly Diagnosed High Stage Medulloblastoma
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1998
Completion date
March 31, 2008
Enrollment
53 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors, central nervous system tumors